KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Net Margin (2016 - 2025)

Historic Net Margin for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to 27.59%.

  • Resmed's Net Margin rose 7100.0% to 27.59% in Q4 2025 from the same period last year, while for Dec 2025 it was 27.53%, marking a year-over-year increase of 21800.0%. This contributed to the annual value of 27.22% for FY2025, which is 54300.0% up from last year.
  • Resmed's Net Margin amounted to 27.59% in Q4 2025, which was up 7100.0% from 26.1% recorded in Q3 2025.
  • Over the past 5 years, Resmed's Net Margin peaked at 28.26% during Q1 2025, and registered a low of 10.21% during Q1 2021.
  • In the last 5 years, Resmed's Net Margin had a median value of 22.4% in 2021 and averaged 21.68%.
  • In the last 5 years, Resmed's Net Margin plummeted by -314100bps in 2021 and then surged by 309200bps in 2022.
  • Quarter analysis of 5 years shows Resmed's Net Margin stood at 22.55% in 2021, then fell by -3bps to 21.76% in 2022, then decreased by -17bps to 17.96% in 2023, then skyrocketed by 50bps to 26.88% in 2024, then rose by 3bps to 27.59% in 2025.
  • Its Net Margin stands at 27.59% for Q4 2025, versus 26.1% for Q3 2025 and 28.17% for Q2 2025.